GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DaVita Inc (BSP:DVAI34) » Definitions » Medicare Income Percentage of Revenue %

DaVita (BSP:DVAI34) Medicare Income Percentage of Revenue % : 0.00% (As of . 20)


View and export this data going back to 2019. Start your Free Trial

What is DaVita Medicare Income Percentage of Revenue %?

Medicare Income Percentage of Revenue % gives the percentage of revenue dedicated to medicare income.

The historical rank and industry rank for DaVita's Medicare Income Percentage of Revenue % or its related term are showing as below:


DaVita Medicare Income Percentage of Revenue % Historical Data

The historical data trend for DaVita's Medicare Income Percentage of Revenue % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DaVita Medicare Income Percentage of Revenue % Chart



DaVita  (BSP:DVAI34) Medicare Income Percentage of Revenue % Explanation

Medicare is a national health insurance program in the United States. The main difference between Medicaid and Medicare is that Medicaid covers healthcare costs for people with low income while Medicare provides health coverage for the elderly.


DaVita Medicare Income Percentage of Revenue % Related Terms

Thank you for viewing the detailed overview of DaVita's Medicare Income Percentage of Revenue % provided by GuruFocus.com. Please click on the following links to see related term pages.


DaVita (BSP:DVAI34) Business Description

Industry
Traded in Other Exchanges
Address
2000 16th Street, Denver, CO, USA, 80202
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

DaVita (BSP:DVAI34) Headlines

No Headlines